[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1254107A1 - 抗trailr2抗體-毒素-偶聯物及其在抗腫瘤治療中的藥物用途 - Google Patents

抗trailr2抗體-毒素-偶聯物及其在抗腫瘤治療中的藥物用途

Info

Publication number
HK1254107A1
HK1254107A1 HK18113173.2A HK18113173A HK1254107A1 HK 1254107 A1 HK1254107 A1 HK 1254107A1 HK 18113173 A HK18113173 A HK 18113173A HK 1254107 A1 HK1254107 A1 HK 1254107A1
Authority
HK
Hong Kong
Prior art keywords
toxin
conjugate
tumor therapy
trailr2 antibody
trailr2
Prior art date
Application number
HK18113173.2A
Other languages
English (en)
Inventor
鄭德先
張書永
潘謳東
鄭超
朱婉
夏清梅
Original Assignee
煙台市和元艾迪斯生物醫藥科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 煙台市和元艾迪斯生物醫藥科技有限公司 filed Critical 煙台市和元艾迪斯生物醫藥科技有限公司
Priority to HK18113173.2A priority Critical patent/HK1254107A1/zh
Publication of HK1254107A1 publication Critical patent/HK1254107A1/zh

Links

HK18113173.2A 2018-10-15 2018-10-15 抗trailr2抗體-毒素-偶聯物及其在抗腫瘤治療中的藥物用途 HK1254107A1 (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK18113173.2A HK1254107A1 (zh) 2018-10-15 2018-10-15 抗trailr2抗體-毒素-偶聯物及其在抗腫瘤治療中的藥物用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HK18113173.2A HK1254107A1 (zh) 2018-10-15 2018-10-15 抗trailr2抗體-毒素-偶聯物及其在抗腫瘤治療中的藥物用途

Publications (1)

Publication Number Publication Date
HK1254107A1 true HK1254107A1 (zh) 2019-07-12

Family

ID=71572044

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18113173.2A HK1254107A1 (zh) 2018-10-15 2018-10-15 抗trailr2抗體-毒素-偶聯物及其在抗腫瘤治療中的藥物用途

Country Status (1)

Country Link
HK (1) HK1254107A1 (zh)

Similar Documents

Publication Publication Date Title
IL270814A (en) Transplanted cytokine antibody proteins and methods of use for cancer treatment
ZA202100195B (en) Purinone compounds and their use in treating cancer
HK1245287A1 (zh) IL13RAα2結合劑和其在癌症治療中的用途
IL284369A (en) Antibody against human IL-4RA and use thereof
SG11202011261PA (en) Urolithin a and derivatives thereof for use in therapy
ZA201904966B (en) Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer
IL273177B (en) Fluorophenyl beta-hydroxyethylamines and their uses in the treatment of hyperglycemia
IL281495A (en) Quinuclidine-3-one derivatives and their use in cancer treatment
ZA201904967B (en) Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer
IL284053A (en) New compounds and their use in therapy
GB201604213D0 (en) Drug combination and its use in therapy
GB201514021D0 (en) Novel Pyridines and their use in the treatment of cancer
GB201507721D0 (en) Immunosuppressive agents and their use in therapy
EP3753579A4 (en) ANTI-TRAILR2 ANTIBODY TOXIN CONJUGATE AND ITS PHARMACEUTICAL USES IN ANTITUM ORTHERAPY
HUE045185T2 (hu) Új terápiás vegyület és terápiában történõ alkalmazása
GB201514015D0 (en) Novel pyridazinones and their use in the treatment of cancer
GB201813312D0 (en) Compounds and their therapeutic use
IL280555A (en) Converted benzamides and their use in therapy
SG11202105276TA (en) Oligo-benzamide analogs and their use in cancer treatment
HK1254107A1 (zh) 抗trailr2抗體-毒素-偶聯物及其在抗腫瘤治療中的藥物用途
PL3752513T3 (pl) Dwujądrowe palladocykle i ich zastosowanie w leczeniu nowotworów złośliwych
EP3544622A4 (en) PEPTIDOMIMETICS AND THEIR THERAPEUTIC USE
GB2581035B (en) Novel compounds and their use in therapy
GB201914640D0 (en) Novel compounds and their use in therapy
GB201913448D0 (en) Novel compounds and their use in therapy